+
Site Tour
AMPLATZER™ AMULET™
LAA OCCLUDER
STRUCTURAL INTERVENTIONS

 

Designed to treat patients with non-valvular atrial fibrillation (AF), who are at risk of ischemic stroke, the Amplatzer™ Amulet™ LAA Occluder offers complete closure of the left atrial appendage (LAA) and immediately eliminates the need for oral anticoagulants (OACs).1

SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion

STROKE RISK REDUCTION AND FREEDOM FROM ANTICOAGULANTS

Clinical studies have shown that implanting AF patients with the Amplatzer™ Amulet™ Occluder is a safe and effective treatment option to reduce their risk of stroke and eliminate the need for oral anticoagulants.

Success
Rate2

Effective
Closure1

Left the hospital
without using OACs1

Reduction
in Stroke Risk2

FIND OUT MORE ABOUT AMULET™ OCCLUDER DATA:

AMULET™ IDE 3 YR DATA  OBSERVATIONAL STUDY

THE AMULET OCCLUDER IS PROVEN TO PROVIDE SUPERIOR COMPLETE CLOSURE1. Head-To-Head study demonstrates 63% lower risk of moderate or greater leaks with Amulet occluder3

Amulet occluder patients had significantly higher complete LAA closure rate by TEE compared to Watchman‡ device at both 45 days and 12 months.

‡Indicates a third party trademark, which is property of its respective owner.

Amplatzer Portfolio App


NEW VERSION AVAILABLE
GET THE AMPLATZER™ PORTFOLIO APP

The Amplatzer™ Portfolio App helps physicians determine which Amplatzer Structural Interventions device to use by suggesting applicable devices based on respective Instructions for Use.

Connext
TV

CONNECT TO THE LATEST
IN STRUCTURAL HEART
THERAPY

Find out more

TV

LAAO in ESKD patients

Dr Ingo Eitel explains why LAAO can be an option in ESKD patients 

ESOC 2023: LAAO case

ESOC 2023: Meet the Expert: Marta Rubiera LAAO challenging case

LAAO Summit 2023: Complications

LAAO 2023: Tips & tricks – Management of complications

LAAO Summit 2023: Successful implant

LAAO 2023: Tips & tricks – How to make the most challenging LAAO case a successful implant

LAAO Summit 2023: Live Case: Salamanca

LAAO 2023: Live case from Salamanca

LAAO Summit 2023: LAA anatomies

LAAO 2023: Anatomy & imaging - LAA anatomies – A first look might be deceiving

LAAO Summit 2023: Anatomy & imaging – Panel

LAAO Summit 2023: Anatomy & imaging – Panel discussion

LAAO Summit 2023: Anatomy & imaging – The future

LAAO Summit 2023: Anatomy & imaging – Future promises and today's realities

LAAO Summit 2023: CT

LAAO 2023: Anatomy & imaging – Do we need CT to really understand the anatomy?

LAAO Summit 2023: LAAO therapies

LAAO 2023: What's new – Trends and recent data for LAA occlusion therapies

References
  1. Lakkireddy D, Thaler D, Ellis CR, et al. Amplatzer™ Amulet™ Left Atrial Appendage Occluder versus Watchman™ device for stroke prophylaxis (Amulet IDE): A randomized, controlled trial. Circulation. 2021; 144(19) :1543–1552. doi.org/10.1161/CIRCULATIONAHA.121.057063.
  2. Hildick-Smith D, Landmesser U, Camm AJ, et al. Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study. Eur Heart J. 2020; 41(30):2894–2901. doi.org/10.1093/eurheartj/ehaa169.
  3. Ellis et al. HRS 2022.

© Abbott 2024. All rights reserved. 9-EH-5-14469-01 03-2024 REV A

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline